Dr. Mehmet Oz to Lead CMS with Focus on Expanding Medicare Advantage
Dr. Mehmet Oz confirmed as CMS Administrator with mandate to protect and grow Medicare Advantage, improving care and reducing costs for seniors.
Dr. Mehmet Oz confirmed as CMS Administrator with mandate to protect and grow Medicare Advantage, improving care and reducing costs for seniors.
Paragon Health Institute updates its research library to provide insights into Medicaid funding reforms and fraud prevention, highlighting systemic issues in federal and state Medicaid financing.
Explore the financial challenges facing U.S. Community Health Centers amid uncertain Medicaid funding and potential federal cuts, impacting healthcare access for vulnerable populations.
Republican lawmakers propose $880 billion Medicaid cuts to finance tax breaks, risking coverage for 20 million. Implications for Medicaid expansion and healthcare providers.
CMS has cut two ACA caseworker teams amid federal staff reductions, risking longer resolution times for 24 million enrollees and raising concerns about fraud and policy change impacts.
Explore the ongoing debate over Medicaid reform as federal spending projections soar and lawmakers face pressure to implement cost-control measures amid rising healthcare costs.
Social Security in Houston faces increasing delays due to staffing cuts and higher call volumes, impacting benefit approvals and service access. Learn how these challenges affect Texas beneficiaries and federal service modernization efforts.
Explore how Medicare Part D and C plans cover Jardiance for heart failure and type 2 diabetes, including costs, formularies, and pricing reforms under the Inflation Reduction Act.
Medicare Advantage faces scrutiny amid efforts to reduce waste in federal healthcare spending, highlighting challenges in cost efficiency and regulatory oversight.
Medicare Part D stand-alone prescription drug plans serve a majority of rural Medicare beneficiaries, with premium stabilization efforts influencing plan availability and affordability in 2025 and beyond.